President Pushes Drug Price Reforms | Charleston News

The President’s latest move on drug pricing unveils new voluntary deals with pharmaceutical companies to slash costs—especially for Medicaid—bringing U.S. prices closer to global averages. While not a sweeping mandate, this strategy builds on past “most-favored-nation” agreements and includes incentives like domestic manufacturing and a presidential discount portal, all aimed at curbing skyrocketing prescription costs ahead of elections. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/15d555ee24aca964